Nuclear Medicine: Page 104

Role of imaging modalities is changing for PE diagnosis
By Eric Barnes
The use of ventilation/perfusion SPECT scans to rule out pulmonary embolism (PE) is evolving. What used to be the definitive test for PE is shifting into a role that harmonizes with the use of pulmonary CT angiography, according to an article in the American Journal of Roentgenology.
March 30, 2017
2016 08 02 15 17 42 85 Lungs Red Body 400
Navidea posts year-end revenue increase
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals has posted a revenue increase for its fiscal 2016.
March 29, 2017
University of Missouri to produce Mo-99
By AuntMinnie.com staff writers
The University of Missouri Research Reactor in Columbia, MO, has submitted a request to the U.S. Nuclear Regulatory Commission to produce medical isotopes, specifically molybdenum-99 (Mo-99).
March 28, 2017
Shine adds new strategic adviser
By AuntMinnie.com staff writers
Shine Medical Technologies has announced that Martyn Coombs will become a strategic adviser on a part-time basis.
March 26, 2017
Gamma Medica wins NY LumaGem installation
By AuntMinnie.com staff writers
Molecular imaging developer Gamma Medica has won a contract with Mercy Medical Center in Rockville Centre, NY, for its LumaGem molecular breast imaging system.
March 23, 2017
ImaginAb names Coombs as CEO
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb has appointed Martyn Coombs to the post of CEO. He replaces Benjamin Chen, PhD, who was named CEO in January 2016.
March 22, 2017
Holst joins NorthStar Medical
By AuntMinnie.com staff writers
NorthStar Medical Radioisotopes announced it has named Lisa Holst as vice president of sales and marketing.
March 22, 2017
Worldwide SPECT market expected to top $1.5B by 2021
By AuntMinnie.com staff writers
The global SPECT market is projected to grow to $1.5 billion U.S. (1.4 billion euros) by 2021, at a compound annual growth rate of more than 5% during the forecast period, according to market research firm Technavio.
March 20, 2017
North American radiopharma market could spike
By AuntMinnie.com staff writers
The North American radiopharmaceuticals market could double from more than $2 billion in 2015 to $4 billion by 2026, according to market research report firm ReportBuyer.
March 19, 2017
Lantheus plans secondary offering of 3M shares
By AuntMinnie.com staff writers
Lantheus Holdings said that certain of its existing stockholders will sell 3 million shares of its common stock in a public secondary offering.
March 13, 2017
MRI debunks 'liberation therapy' | PET/CT guides pediatric cancer biopsy | 8 ways to win turf battles
By Brian Casey
March 8, 2017
Piramal partner gets Canadian approval for Neuraceq
By AuntMinnie.com staff writers
Piramal Imaging's partner in Canada has received marketing authorization from Health Canada to begin commercial production and distribution of its Neuraceq radiotracer for diagnosing Alzheimer's disease.
March 7, 2017
Previous Page
Page 104 of 445
Next Page